Study on Diagnosis Value of mNGS Technology Among Diabetic Patients With Pulmonary Infections
NCT ID: NCT05552872
Last Updated: 2022-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-09-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Appropriate Technology of Standardized Diagnosis and Treatment for Diabetic Patients With Pulmonary Infections
NCT03617393
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
NCT07248371
The Alteration of Gut Microbiota and Analysis of Related Factors in Newly Diagnosed Type 2 Diabetes Patients
NCT05752851
Raman Spectroscopy-Based Non-Invasive Blood Glucose Detection
NCT07311421
The Role of Skin Microecology in Diabetic Skin Lesions
NCT04916457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The final purpose is to find out the difference in etiologic spectrum and host immune on lower respiratory infection between diabetes patients and controls. Now investigators wish to register this study to do a further research, in order to improve the diagnosis value of diabetes complicated with pulmonary infection and to reduce the mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Infection with DM group
Patients with diabetes and pulmonary infection
mNGS, IDSeq UltraTM
pathogen detection
Pulmonary Infection group
Patients with pulmonary infection while the fasting blood-glucose in the normal range.
mNGS, IDSeq UltraTM
pathogen detection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mNGS, IDSeq UltraTM
pathogen detection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis through X-ray or CT: characteristic features of pulmonary infection
* Age older than 18 years
Exclusion Criteria
* Withdraw from the study for any reason
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZHOU Min
Chief Physician of Department of Respiratory Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jieming Qu, Ph.D., M.D.
Role: PRINCIPAL_INVESTIGATOR
China, Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022Ultra
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.